PRF plus PRP improves pain, sleep quality, quality of life, and inflammation more than PRF alone or PRF plus ozone in postherpetic neuralgia patients at 90 days
In a single-center RCT of 122 adults aged 50-70 with single-segment PHN lasting >3 months, PRF plus PRP showed significantly greater improvement at 90 days compared to PRF alone and PRF plus ozone. VAS reduction was -2.49 (95% CI, -2.88 to -2.10) vs PRF alone and -1.43 (-1.80 to -1.05) vs PRF plus ozone; PSQI improved by -5.72 (-7.09 to -4.36) and -4.77 (-6.09 to -3.44), respectively; all adjusted P values <0.001.
Evidence Score
Study Evidence
Study 1. CT-Guided Dorsal Root Ganglion Pulsed Radiofrequency Alone, with Ozone, or with Platelet-Rich Plasma for Postherpetic Neuralgia: A Randomized Controlled Trial.
observationalCao K, Wu J, Zhang J ยท Journal of pain research (2026)
Result:
Mechanism Graph
Limitations
- โ Single-center design limits generalizability
- โ Results require validation in larger, well-designed multicenter randomized trials
- โ Complete-case/per-protocol analysis may introduce bias if dropouts were not random
Frequently Asked Questions
What is the main finding of this study?โผ
PRF plus PRP was more effective than PRF alone or PRF plus ozone for improving pain, sleep quality, quality of life, and inflammation in postherpetic neuralgia patients at 90 days.
How many participants were in the study?โผ
122 participants completed the trial: 38 in PRF alone, 43 in PRF plus ozone, and 41 in PRF plus PRP.
What outcomes were measured?โผ
Pain (VAS), sleep quality (PSQI), quality of life (SF-12), and inflammation (neutrophil-to-lymphocyte ratio) were assessed at baseline and 30, 60, and 90 days.
Are there any safety concerns with PRP?โผ
No PRP-related complications were observed in this study.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Cao K, Wu J, Zhang J. "CT-Guided Dorsal Root Ganglion Pulsed Radiofrequency Alone, with Ozone, or with Platelet-Rich Plasma for Postherpetic Neuralgia: A Randomized Controlled Trial.." Journal of pain research, 2026. PMID: 42502491 DOI: 10.2147/JPR.S605629